Community Acquired Pneumonia

Community acquired pneumonia is a common disease, and it is usually managed by empirical antibiotics therapy from several management guidelines. It is challenged by emergence of drug resistant bacterial strains, especially Streptococcus pneumoniae and recent increasing recognition for the mixed infection by atypical pneumonia pathogens such as Mycoplasma, Chlamydia and Legionella species. Even though community acquired pneumoniae caused by drug resistant S. pneumoina is common in Korea, the treatment results are good with current antibiotics. This review deals with important new findings and management issues of community acquired pneumonia in immunocompetent adults.ope